Omar Abdel-Mannan1, Michael Eyre1, Ulrike Löbel2, Alasdair Bamford3, Christin Eltze4, Biju Hameed1, Cheryl Hemingway4, Yael Hacohen1,5. 1. Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom. 2. Department of Neuroradiology, Great Ormond Street Hospital for Children, London, United Kingdom. 3. UCL Great Ormond Street Institute of Child Health, Department of Infectious Disease, Great Ormond Street Hospital for Children, London, United Kingdom. 4. UCL Great Ormond Street Institute of Child Health, Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom. 5. Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom.
Abstract
Importance: Neurological manifestations have been reported in adults with coronavirus disease 2019 (COVID-19), which is caused by the highly pathogenic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objective: To report the neurological manifestations of children with COVID-19. Design, Setting, and Participants: In this case-series study, patients younger than 18 years who presented with SARS-CoV-2 infection and neurological symptoms to Great Ormond Street Hospital for Children (London, UK) between March 1, 2020, and May 8, 2020, were included after infection was confirmed by either a quantitative reverse transcription-polymerase chain reaction assay by nasopharyngeal swab or a positive test result for IgG antibodies against SARS-CoV-2 in serum. Main Outcomes and Measures: Clinical and paraclinical features were retrieved from electronic patient records. Results: Of the 27 children with COVID-19 pediatric multisystem inflammatory syndrome, 4 patients (14.8%) who were previously healthy had new-onset neurological symptoms. Symptoms included encephalopathy, headaches, brainstem and cerebellar signs, muscle weakness, and reduced reflexes. All 4 patients required intensive care unit admission for the treatment of COVID-19 pediatric multisystem inflammatory syndrome. Splenium signal changes were seen in all 4 patients on magnetic resonance imaging of the brain. In the 2 patients whose cerebrospinal fluid was tested, samples were acellular, with no evidence of infection on polymerase chain reaction or culture (including negative SARS-CoV-2 polymerase chain reaction results) and negative oligoclonal band test results. In all 3 patients who underwent electroencephalography, a mild excess of slow activity was found. Tests for N-methyl-d-aspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients. In all 3 patients who underwent nerve conduction studies and electromyography, mild myopathic and neuropathic changes were seen. Neurological improvement was seen in all patients, with 2 making a complete recovery by the end of the study. Conclusions and Relevance: In this case-series study, children with COVID-19 presented with new neurological symptoms involving both the central and peripheral nervous systems and splenial changes on imaging, in the absence of respiratory symptoms. Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19.
Importance: Neurological manifestations have been reported in adults with coronavirus disease 2019 (COVID-19), which is caused by the highly pathogenic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objective: To report the neurological manifestations of children with COVID-19. Design, Setting, and Participants: In this case-series study, patients younger than 18 years who presented with SARS-CoV-2 infection and neurological symptoms to Great Ormond Street Hospital for Children (London, UK) between March 1, 2020, and May 8, 2020, were included after infection was confirmed by either a quantitative reverse transcription-polymerase chain reaction assay by nasopharyngeal swab or a positive test result for IgG antibodies against SARS-CoV-2 in serum. Main Outcomes and Measures: Clinical and paraclinical features were retrieved from electronic patient records. Results: Of the 27 children with COVID-19 pediatric multisystem inflammatory syndrome, 4 patients (14.8%) who were previously healthy had new-onset neurological symptoms. Symptoms included encephalopathy, headaches, brainstem and cerebellar signs, muscle weakness, and reduced reflexes. All 4 patients required intensive care unit admission for the treatment of COVID-19 pediatric multisystem inflammatory syndrome. Splenium signal changes were seen in all 4 patients on magnetic resonance imaging of the brain. In the 2 patients whose cerebrospinal fluid was tested, samples were acellular, with no evidence of infection on polymerase chain reaction or culture (including negative SARS-CoV-2 polymerase chain reaction results) and negative oligoclonal band test results. In all 3 patients who underwent electroencephalography, a mild excess of slow activity was found. Tests for N-methyl-d-aspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients. In all 3 patients who underwent nerve conduction studies and electromyography, mild myopathic and neuropathic changes were seen. Neurological improvement was seen in all patients, with 2 making a complete recovery by the end of the study. Conclusions and Relevance: In this case-series study, children with COVID-19 presented with new neurological symptoms involving both the central and peripheral nervous systems and splenial changes on imaging, in the absence of respiratory symptoms. Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19.
Authors: Dongngan T Truong; Felicia L Trachtenberg; Gail D Pearson; Audrey Dionne; Matthew D Elias; Kevin Friedman; Kerri H Hayes; Lynn Mahony; Brian W McCrindle; Matthew E Oster; Victoria Pemberton; Andrew J Powell; Mark W Russell; Lara S Shekerdemian; Mary Beth Son; Michael Taylor; Jane W Newburger Journal: Am Heart J Date: 2021-08-19 Impact factor: 4.749
Authors: Ariane Lewis; Rajan Jain; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Kara R Melmed Journal: J Neuroimaging Date: 2021-06-08 Impact factor: 2.324
Authors: J M Plasencia-Martínez; À Rovira; P Caro Domínguez; I Barber; E García-Garrigós; J J Arenas-Jiménez Journal: Radiologia (Engl Ed) Date: 2021-05-19
Authors: L Siracusa; A Cascio; S Giordano; A A Medaglia; G A Restivo; I Pirrone; G F Saia; F Collura; C Colomba Journal: Ital J Pediatr Date: 2021-06-02 Impact factor: 2.638
Authors: Lama Aljomah; Sara Almedlej; Duaa Baarmah; Waleed Altwaijri; Ahmad Alrumayyan; Muhammad Talal Alrifai; Mohammed Almuqbil; Mohammad Alshalaan Journal: eNeurologicalSci Date: 2021-07-09